Cargando…

RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis

OBJECTIVE: Previous studies have reported that Ras-associated domain family 1A (RASSF1A), the most commonly silenced tumor suppressor via promoter methylation, played vital roles in the development of carcinogenesis. The purpose of this meta-analysis was to determine whether RASSF1A promoter methyla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shou, Feiyan, Xu, Feng, Li, Gang, Zhao, Zhenhua, Mao, Ying, Yang, Fangfang, Wang, Hongming, Guo, Hangyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234557/ https://www.ncbi.nlm.nih.gov/pubmed/28123306 http://dx.doi.org/10.2147/OTT.S124417

Ejemplares similares

Predictive value of the serum RASSF10 promoter methylation status in gastric cancer
por: Hu, Yilin, et al.
Publicado: (2019)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer
por: Meng, Wei, et al.
Publicado: (2012)

Association between RASSF1A Promoter Methylation and Ovarian Cancer: A Meta-Analysis
por: Shi, Hao, et al.
Publicado: (2013)

The Role of TSHR, PTEN and RASSF1A Promoters’ Methylation Status for Non-Invasive Detection of Papillary Thyroid Carcinoma
por: Klimaitė, Raimonda, et al.
Publicado: (2022)

The relationship between RASSF1A promoter methylation and thyroid carcinoma: A meta-analysis of 14 articles and a bioinformatics of 2 databases (PRISMA)
por: Niu, Heng, et al.
Publicado: (2017)

The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics
por: Shao, Chihao, et al.
Publicado: (2017)

The Role of RASSF1A Methylation in Cancer
por: Hesson, Luke B., et al.
Publicado: (2007)

Tumor Suppressor RASSF1A Promoter: p53 Binding and Methylation
por: Tian, Yihao, et al.
Publicado: (2011)

The Prognostic Role of RASSF1A Promoter Methylation in Breast Cancer: A Meta-Analysis of Published Data
por: Jiang, Yong, et al.
Publicado: (2012)

Association between RASSF1A Promoter Methylation and Prostate Cancer: A Systematic Review and Meta-Analysis
por: Pan, Jincheng, et al.
Publicado: (2013)

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1
por: Volodko, Natalia, et al.
Publicado: (2016)

Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer
por: Guo, Qiang, et al.
Publicado: (2016)

Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China
por: Ye, Mei, et al.
Publicado: (2007)

Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas
por: Muñoz, Jorge, et al.
Publicado: (2012)

Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis
por: Meng, Rui-Wei, et al.
Publicado: (2016)

Diagnostic value of RASSF1A methylation for breast cancer: a meta-analysis
por: Li, Mingyi, et al.
Publicado: (2019)

RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker
por: Jin, Yongshuai, et al.
Publicado: (2015)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
por: Xu, Jia, et al.
Publicado: (2012)

Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors
por: Malpeli, Giorgio, et al.
Publicado: (2011)

Clinical utility of RASSF1A methylation in human malignancies
por: Grawenda, A M, et al.
Publicado: (2015)

Methylation Dynamics of RASSF1A and Its Impact on Cancer
por: Malpeli, Giorgio, et al.
Publicado: (2019)

Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
por: Schagdarsurengin, Undraga, et al.
Publicado: (2010)

Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer
por: Yadav, Prasant, et al.
Publicado: (2018)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

The Intronic Long Noncoding RNA ANRASSF1 Recruits PRC2 to the RASSF1A Promoter, Reducing the Expression of RASSF1A and Increasing Cell Proliferation
por: Beckedorff, Felipe C., et al.
Publicado: (2013)

Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
por: Richter, Antje M., et al.
Publicado: (2016)

Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA)
por: Zhan, Leyun, et al.
Publicado: (2017)

Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer
por: Gil, Eun Young, et al.
Publicado: (2017)

RASSF Family Proteins
por: Clark, Geoffrey J., et al.
Publicado: (2012)

Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma
por: Du, Zhenzong, et al.
Publicado: (2015)

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2015)

RASSF1 Polymorphisms in Cancer
por: Gordon, Marilyn, et al.
Publicado: (2012)

Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma
por: Wang, Tao, et al.
Publicado: (2009)

Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers
por: Riffet, Marc, et al.
Publicado: (2021)

RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis
por: Peters, Inga, et al.
Publicado: (2007)

Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer
por: Spitzwieser, Melanie, et al.
Publicado: (2015)

Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals
por: Cao, Xue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pa7umgt180lqfuk0maiokj69rs